Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est
Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805 billion-$2.885
Medpace said it will make more money and sell more stuff next year than it thought before—both better than what experts predicted. When a company raises its own forecast, it usually means things are going better than expected, which is worth noticing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.